Development and evaluation of a patient-centered electronic outcome assessment (strokePRO) system for acute stroke trials
Summary
In this project, we aim to design an electronic tool, called strokePRO, which will allow for easier collection of stroke outcome assessments for patients participating in stroke clinical trials. The first step of our research involves meaningfully engaging with stroke patients and/or caregivers to understand patients' experiences and priorities regarding outcome assessment after a stroke.
Thus, we are recruiting up to 60 ischemic stroke patients and/or stroke patient caregivers, to participate in this research study. Participation in this study would involve two parts:
1) First, you would be asked to attend an online one-on-one meeting with a member of our research team, where you would be presented with findings of previous stroke research priorities and outcomes of an electronic clinical outcome assessment tool. We would also ask you if there are any additional priorities or outcomes you feel are missing, and then have you rank them. This interview would be conducted through a digital format (i.e. Zoom video conferencing).
2) Second, you would be asked to attend an online focus group with up to 5 stroke patients and caregivers. In these focus groups, we will ask our participants about their thoughts on how they are being assessed after a stroke, their experiences with participating in previous stroke trials, and their preferences for being assessed for stroke outcomes. These focus groups will be conducted using semi-structured interview guides through a digital format (i.e. Zoom video conferencing).
All participants will be compensated for their time and contributions.
Eligibility
Eligible ages: 18 to 100
Inclusion criteria:
The inclusion criteria are defined as:
1. Lived experience with ischemic stroke or transient ischemic attack OR previous or current caregiving experience for someone with a stroke
2. ability to provide informed consent
3. ability to read and communicate in English or French
Exclusion criteria:
Individuals will be considered ineligible for this study if they have significant impairment and are without a caregiver, or they are unable to read or communicate in English or French.
Participate
Fill out the following form if you want to participate in this research
UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is
committed to ensuring the privacy of all students, staff, and community members. Your personal information is being
collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used
and disclosed for the purposes outlined in UCalgary’s
Notice of
Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s
Privacy
Management Program.
Your personal information may be input into automated systems to generate content or make decisions,
recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection,
use, or disclosure of your personal information, please contact
accessandprivacy@ucalgary.ca.
Additional information
Contact information
Tomi Adebowale
Principal investigator:
Tolulope Sajobi
Clinical trial:
No
REB-ID:
REB23-1669